National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings, 1863-1864 [2013-00175]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 6 / Wednesday, January 9, 2013 / Notices
Independent Container Line Ltd.;
Kawasaki Kisen Kaisha, Ltd.; Nippon
Yusen Kaisha; Norasia Container Lines
Limited; Safmarine Container Lines
N.V.; United Arab Shipping Company
(S.A.G.); Wallenius Wilhelmsen
Logistics AS; YangMing Marine
Transport Corp.; Zim Integrated
Shipping Services, Ltd.
Filing Party: Wayne R. Rohde, Esq.;
Cozen O’Connor; 1627 I Street NW.,
Suite 1100; Washington, DC 20006.
Synopsis: The amendment removes
Hoegh Autoliners A/S. as party to the
Agreement.
Agreement No.: 012128–002.
Title: Southern Africa Agreement.
Parties: A.P. Moller-Maersk A/S
trading under the name Maersk Line,
and Mediterranean Shipping Company
S.A.
Filing Party: Wayne R. Rohde,
Esquire; Cozen O’Connor; 1627 I Street
NW., Suite 1100; Washington, DC
20006–4007.
Synopsis: The amendment deletes
Safmarine Container Lines N.V. as a
party to the agreement and makes the
corresponding technical corrections
necessary to reflect the fact that the
agreement has only two parties.
Application Type: Delete Trade Name
Siam Intercargo Services/QI Change.
Carmichael International Service dba
C.I. Container Line (NVO & OFF), 533
Glendale Blvd., Los Angeles, CA
90026, Officers: John Salvo, CoPresident (QI), Vincent Salvo, CoPresident, Application Type: QI
Change.
OTA America, Inc. (NVO & OFF), 927
Teak Street, Brea, CA 92821, Officers:
Dookee Kim, Secretary (QI),
Kyoungmi Lee, CEO, Application
Type: New NVO & OFF License.
Salmad Ocean Line & Logistics, Inc.
(NVO & OFF), 4854 Old National
Hwy., Suite 205, College Park, GA
30337, Officer: Amadu K. Jah,
President (QI), Application Type:
Name Change to Sea Freight Express,
Inc.
Watercraft Mix, Inc. (NVO & OFF), 4380
E. 11th Avenue, Hialeah, FL 33013,
Officer: Dmitry Poyarkov, President
(QI),
Application Type: QI Change.
By the Commission.
Dated: January 4, 2013.
Karen V. Gregory,
Secretary.
1863
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Kausik Ray, Ph.D.,
Scientific Review Officer, National Institute
on Deafness and Other Communication
Disorders, National Institutes of Health,
Rockville, MD 20850, 301–402–3587,
rayk@nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special, Emphasis Panel, NIDCD
P30 Review Meeting.
Date: March 8, 2013.
Time: 8:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Kausik Ray, Ph.D.,
Scientific Review Officer, National Institute
on Deafness and Other Communication
Disorders, National Institutes of Health,
Rockville, MD 20850, 301–402–3587,
rayk@nidcd.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
[FR Doc. 2013–00273 Filed 1–8–13; 8:45 am]
BILLING CODE 6730–01–P
By Order of the Federal Maritime
Commission.
Dated: January 4, 2013.
Karen V. Gregory,
Secretary.
Dated: January 3, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–00176 Filed 1–8–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
[FR Doc. 2013–00274 Filed 1–8–13; 8:45 am]
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel,
Chemosensory Fellowships Review Meeting.
Date: February 22, 2013.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel, Middle
Ear P50 Review.
Date: February 8, 2013.
Time: 4:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
BILLING CODE 6730–01–P
FEDERAL MARITIME COMMISSION
srobinson on DSK4SPTVN1PROD with
Ocean Transportation Intermediary
License Applicants
The Commission gives notice that the
following applicants have filed an
application for an Ocean Transportation
Intermediary (OTI) license as a NonVessel-Operating Common Carrier
(NVO) and/or Ocean Freight Forwarder
(OFF) pursuant to section 19 of the
Shipping Act of 1984 (46 U.S.C. 40101).
Notice is also given of the filing of
applications to amend an existing OTI
license or the Qualifying Individual (QI)
for a licensee.
Interested persons may contact the
Office of Ocean Transportation
Intermediaries, Federal Maritime
Commission, Washington, DC 20573, by
telephone at (202) 523–5843 or by email
at OTI@fmc.gov.
Best Global Logistics USA, Inc. dba
Siam Intercargo Services (NVO &
OFF), 1207 West Mahalo Place, Suite
100, Compton, CA 90220, Officers:
Tai-Chuen (Larry) Che, Vice President
(QI), Wing-Ham Chu, Director,
VerDate Mar<15>2010
16:39 Jan 08, 2013
Jkt 229001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
E:\FR\FM\09JAN1.SGM
09JAN1
1864
Federal Register / Vol. 78, No. 6 / Wednesday, January 9, 2013 / Notices
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Christine A. Livingston,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institutes of
Health/NIDCD, 6120 Executive Blvd.—MSC
7180, Bethesda, MD 20892, (301) 496–8683,
livingsc@mail.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel, Chemical
Senses Clinical Trial Review.
Date: February 28, 2013.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852.
Contact Person: Christine A. Livingston,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institutes of
Health/NIDCD, 6120 Executive Blvd.—MSC
7180, Bethesda, MD 20892, (301) 496–8683,
livingsc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: January 3, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–00175 Filed 1–8–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
srobinson on DSK4SPTVN1PROD with
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel
Phase II Trials in Lung Disease.
Date: February 1, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Washington DC,
Dupont Circle, 1143 New Hampshire Avenue
NW., Washington, DC 20037.
VerDate Mar<15>2010
16:39 Jan 08, 2013
Jkt 229001
Contact Person: Stephanie L. Constant,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7189, Bethesda, MD 20892, 301–
443–8784, constantsl@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: January 3, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–00172 Filed 1–8–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group,
Pregnancy and Neonatology Study Section.
Date: February 5–6, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michael Knecht, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6176,
MSC 7892, Bethesda, MD 20892, (301) 435–
1046, knechtm@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group, Sensorimotor
Integration Study Section.
Date: February 8, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina Santa Monica
Hotel, 530 West Pico Boulevard, Santa
Monica, CA 90405.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Contact Person: John Bishop, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group,
Dissemination and Implementation Research
in Health Study Section.
Date: February 8, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Jacinta Bronte-Tinkew,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164,
MSC 7770, Bethesda, MD 20892, (301) 806–
0009, brontetinkewjm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, RFA Panel:
System Science and Health in the Behavioral
and Social Sciences.
Date: February 8, 2013.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Inner Harbor, 301 W.
Lombard Street, Baltimore, MD 21201.
Contact Person: Tomas Drgon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3152,
MSC 7770, Bethesda, MD 20892, 301–435–
1017, tdrgon@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Cancer
Therapeutics Area Grant Application.
Date: February 8, 2013.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Dupont Circle Hotel, 1500 New
Hampshire Avenue NW., Washington, DC
20036.
Contact Person: Denise R. Shaw, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7804, Bethesda, MD 20892, 301–435–
0198, shawdeni@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR–10–
018 Accelerating the Pace of Drug Abuse
Research Using Existing Epidemiology,
Prevention, and Treatment Research Data.
Date: February 8, 2013.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: George Vogler, Ph.D.,
Scientific Review Officer, PSE IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3140,
Bethesda, MD 20892, 301–435–0694,
voglergp@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR 11–
E:\FR\FM\09JAN1.SGM
09JAN1
]]>Agencies
[Federal Register Volume 78, Number 6 (Wednesday, January 9, 2013)]
[Notices]
[Pages 1863-1864]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-00175]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Deafness and Other
Communication Disorders Special Emphasis Panel, Middle Ear P50
Review.
Date: February 8, 2013.
Time: 4:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 1864]]
Place: National Institutes of Health, 6120 Executive Blvd.,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Christine A. Livingston, Ph.D., Scientific
Review Officer, Division of Extramural Activities, National
Institutes of Health/NIDCD, 6120 Executive Blvd.--MSC 7180,
Bethesda, MD 20892, (301) 496-8683, livingsc@mail.nih.gov.
Name of Committee: National Institute on Deafness and Other
Communication Disorders Special Emphasis Panel, Chemical Senses
Clinical Trial Review.
Date: February 28, 2013.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6120 Executive Blvd.,
Rockville, MD 20852.
Contact Person: Christine A. Livingston, Ph.D., Scientific
Review Officer, Division of Extramural Activities, National
Institutes of Health/NIDCD, 6120 Executive Blvd.--MSC 7180,
Bethesda, MD 20892, (301) 496-8683, livingsc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.173,
Biological Research Related to Deafness and Communicative Disorders,
National Institutes of Health, HHS)
Dated: January 3, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-00175 Filed 1-8-13; 8:45 am]
BILLING CODE 4140-01-P
